Results 11 to 20 of about 2,605,294 (243)

Enhanced Recovery after Surgery (ERAS) Program for Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery with or without HIPEC: A Systematic Review and a Meta-Analysis

Cancers, 2023
Simple Summary Cytoreductive surgery and Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) represent a promising treatment strategy for the management of selected cases of peritoneal cancer, but it’s still burdened by significant morbidity and prolonged ...
M. Robella, M. Tonello, P. Berchialla, V. Sciannameo, Alba Ilari Civit, A. Sommariva, C. Sassaroli, A. di Giorgio, R. Gelmini, V. Ghirardi, F. Roviello, F. Carboni, P. Lippolis, S. Kusamura, M. Vaira   +14 more
semanticscholar   +1 more source

The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.

JAMA Surgery, 2021
Importance Studies on the prognostic role of hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei (PMP) are currently not available.
S. Kusamura, F. Barretta, Y. Yonemura, P. Sugarbaker, B. Moran, E. Levine, D. Goéré, D. Baratti, E. Nizri, D. Morris, O. Glehen, A. Sardi, P. Barrios, F. Quénet, L. Villeneuve, A. Gómez-Portilla, I. D. de Hingh, W. Ceelen, J. Pelz, P. Piso, S. González-Moreno, K. van der Speeten, M. Deraco   +22 more
semanticscholar   +1 more source

Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis

Journal of Gynecologic Oncology, 2022
Objective Advances in ovarian cancer cytoreductive surgery have enabled more extensive procedures to achieve maximal cytoreduction but with a consequent increase in postoperative morbidity and mortality.
M. Kengsakul, G. N. Nieuwenhuyzen-de Boer, S. Udomkarnjananun, S. J. Kerr, C. Niehot, H. V. van Beekhuizen   +5 more
semanticscholar   +1 more source

A pre-operative predictive score to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer. [PDF]

PLoS ONE, 2017
OBJECTIVE:Postoperative residual tumor is the major prognostic factor in ovarian cancer. The feasibility of complete cytoreductive surgery is assessed by laparoscopy.
Marion Chesnais, Fabrice Lecuru, Myriam Mimouni, Charlotte Ngo, Arnaud Fauconnier, Cyrille Huchon   +5 more
doaj   +1 more source

Multimodal CEA-targeted fluorescence and radioguided cytoreductive surgery for peritoneal metastases of colorectal origin

Nature Communications, 2022
In patients with colorectal peritoneal metastases scheduled for cytoreductive surgery, accurate preoperative estimation of tumor burden and subsequent intraoperative detection of all tumor deposits remains challenging.
J. D. de Gooyer, F. M. Elekonawo, A. Bremers, O. Boerman, E. Aarntzen, P. D. de Reuver, I. Nagtegaal, M. Rijpkema, J. D. de Wilt   +8 more
semanticscholar   +1 more source

Cytoreductive Surgery [PDF]

Definitions, 2020
openaire   +2 more sources

Feasibility of a Multimodal Prehabilitation Programme in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer: A Pilot Study

Cancers, 2022
Simple Summary Multimodal prehabilitation programmes represent an innovative approach to promoting surgical recovery by improving the physiological and psychological baseline resilience in conjunction with nutritional optimisation in order to reduce the ...
B. Díaz-Feijóo, Nuria Agusti-Garcia, Raquel Sebio, A. López-Hernández, Marina Sisó, A. Glickman, Núria Carreras-Dieguez, P. Fusté, T. Marina, Judit Martínez-Egea, Laura Aguilera, J. Perdomo, Amaia Peláez, M. López-Baamonde, R. Navarro-Ripoll, E. Gimeno, Betina Campero, A. Torné, G. Martínez-Pallí, M. Arguis   +19 more
semanticscholar   +1 more source

Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique

BMC Surgery, 2021
Background This study investigated the feasibility and safety of laparoscopic splenectomy conducted in the contexts of both laparoscopic secondary surgery for isolated recurrence in the spleen and primary laparoscopic cytoreductive surgery for advanced ...
Antonio Macciò, Elisabetta Sanna, Fabrizio Lavra, Giacomo Chiappe, Marco Petrillo, Clelia Madeddu   +5 more
doaj   +1 more source

Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01)

Journal of Gynecologic Oncology, 2022
Objective To investigate the health-related quality of life (HRQOL) related to hyperthermic intraperitoneal chemotherapy (HIPEC) following primary or interval cytoreductive surgery for primary ovarian cancer. Methods Between 2010 and 2016, a total of 184
J. Kim, Dong-eun Lee, Yumi Lee, H. I. Ha, Y. Chang, Suk-Joon Chang, Sang-Yoon Park, M. Lim   +7 more
semanticscholar   +1 more source

Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis

Journal of Clinical Oncology, 2021
PURPOSE The survival impact of secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer was studied. METHODS We identified published studies from 1983 to 2021 following our inclusion criteria from MEDLINE, EMBASE, and ...
M. Baek, E. Park, H. I. Ha, S. Park, M. Lim, C. Fotopoulou, R. Bristow   +6 more
semanticscholar   +1 more source